BANK OF AMERICA CORP /DE/ - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 56 filers reported holding SPERO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,626
-44.6%
8,782
-33.7%
0.00%
Q2 2023$19,193
-28.1%
13,237
-28.1%
0.00%
Q1 2023$26,705
+94.5%
18,417
+132.0%
0.00%
Q4 2022$13,733
-27.7%
7,938
-18.8%
0.00%
Q3 2022$19,000
+35.7%
9,781
-47.3%
0.00%
Q2 2022$14,000
-83.5%
18,575
+89.3%
0.00%
Q1 2022$85,000
-87.3%
9,810
-76.4%
0.00%
Q4 2021$667,000
+165.7%
41,653
+204.7%
0.00%
Q3 2021$251,000
+134.6%
13,668
+77.5%
0.00%
Q2 2021$107,000
-61.4%
7,701
-59.1%
0.00%
Q1 2021$277,000
+59.2%
18,819
+109.8%
0.00%
Q4 2020$174,000
+4.2%
8,969
-40.3%
0.00%
Q3 2020$167,000
-26.1%
15,012
-10.4%
0.00%
Q2 2020$226,000
+182.5%
16,748
+68.8%
0.00%
Q1 2020$80,000
-54.3%
9,919
-45.6%
0.00%
Q4 2019$175,000
+10.1%
18,226
+21.7%
0.00%
Q3 2019$159,000
+21.4%
14,973
+31.7%
0.00%
Q2 2019$131,000
-87.6%
11,370
-86.2%
0.00%
Q1 2019$1,055,000
+106.9%
82,439
-0.7%
0.00%
Q4 2018$510,000
+1143.9%
83,009
+2036.1%
0.00%
Q3 2018$41,000
+46.4%
3,886
+106.6%
0.00%
Q2 2018$28,000
+366.7%
1,881
+309.8%
0.00%
Q1 2018$6,000
-50.0%
459
-52.6%
0.00%
Q4 2017$12,0009690.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,376,968$17,639,00016.57%
Aquilo Capital Management, LLC 1,054,356$13,506,0005.98%
VHCP Management II, LLC 474,015$6,072,0001.78%
AWM Investment Company, Inc. 562,296$7,203,0001.42%
Alphabet Inc. 1,112,473$14,251,0000.74%
BVF INC/IL 460,706$5,902,0000.66%
DAFNA Capital Management LLC 70,000$897,0000.39%
Artal Group S.A. 600,000$7,686,0000.31%
Rock Springs Capital Management LP 525,000$6,725,0000.26%
Orbimed Advisors 507,471$6,501,0000.10%
View complete list of SPERO THERAPEUTICS INC shareholders